These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 28232276)

  • 21. Phytocannabinoids as novel therapeutic agents in CNS disorders.
    Hill AJ; Williams CM; Whalley BJ; Stephens GJ
    Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
    Roser P; Vollenweider FX; Kawohl W
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease.
    Kicman A; Toczek M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
    Hayakawa K; Mishima K; Fujiwara M
    Pharmaceuticals (Basel); 2010 Jul; 3(7):2197-2212. PubMed ID: 27713349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.
    Kogan NM; Melamed E; Wasserman E; Raphael B; Breuer A; Stok KS; Sondergaard R; Escudero AV; Baraghithy S; Attar-Namdar M; Friedlander-Barenboim S; Mathavan N; Isaksson H; Mechoulam R; Müller R; Bajayo A; Gabet Y; Bab I
    J Bone Miner Res; 2015 Oct; 30(10):1905-13. PubMed ID: 25801536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
    Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
    Taffe MA; Creehan KM; Vandewater SA
    Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidative and Anti-Inflammatory Properties of Cannabidiol.
    Atalay S; Jarocka-Karpowicz I; Skrzydlewska E
    Antioxidants (Basel); 2019 Dec; 9(1):. PubMed ID: 31881765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol, a Regulator of Intracellular Calcium and Calpain.
    Jeon KH; Park SH; Bae WJ; Kim SW; Park HJ; Kim S; Kim TH; Jeon SH; Park I; Park HJ; Kwon Y
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):119-125. PubMed ID: 35196129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.
    Noreen N; Muhammad F; Akhtar B; Azam F; Anwar MI
    Crit Rev Eukaryot Gene Expr; 2018; 28(1):73-86. PubMed ID: 29773016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.
    Boyaji S; Merkow J; Elman RNM; Kaye AD; Yong RJ; Urman RD
    Curr Pain Headache Rep; 2020 Jan; 24(2):4. PubMed ID: 31980957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.
    Fowler CJ
    Clin Pharmacol Ther; 2015 Jun; 97(6):587-96. PubMed ID: 25669486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease.
    Silvestro S; Schepici G; Bramanti P; Mazzon E
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.
    Kozela E; Juknat A; Vogel Z
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
    Kis B; Ifrim FC; Buda V; Avram S; Pavel IZ; Antal D; Paunescu V; Dehelean CA; Ardelean F; Diaconeasa Z; Soica C; Danciu C
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.